COTQF (Cotinga Pharmaceuticals) Total Inventories : $0.00 Mil (As of Jan. 2020)

View and export this data going back to 2007. Start your Free Trial

What is Cotinga Pharmaceuticals Total Inventories?

Cotinga Pharmaceuticals's total inventories for the quarter that ended in Jan. 2020 was $0.00 Mil. Cotinga Pharmaceuticals's average total inventories from the quarter that ended in Oct. 2019 to the quarter that ended in Jan. 2020 was $0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Cotinga Pharmaceuticals's Net-Net Working Capital per share for the quarter that ended in Jan. 2020 was $-0.17.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cotinga Pharmaceuticals Total Inventories Historical Data

The historical data trend for Cotinga Pharmaceuticals's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cotinga Pharmaceuticals Total Inventories Chart

Cotinga Pharmaceuticals Annual Data

Trend

Apr10

Apr11

Apr12

Apr13

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Total Inventories

Get a 7-Day Free Trial

Cotinga Pharmaceuticals Quarterly Data
	Apr15	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20
Total Inventories	Get a 7-Day Free Trial															-	-	-	-	-

Cotinga Pharmaceuticals Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Cotinga Pharmaceuticals (OTCPK:COTQF) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Cotinga Pharmaceuticals's Net-Net Working Capital Per Share for the quarter that ended in Jan. 2020 is

	Net-Net Working Capital Per Share (Q: Jan. 2020 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0.035	+	0.75 * 0	+	0.5 * 0	-	3.677
-	0	-	0)	/	21.9864
=	-0.17

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cotinga Pharmaceuticals's Days Inventory for the three months ended in Jan. 2020 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Jan. 2020 )	/	Cost of Goods Sold (Q: Jan. 2020 )	*	Days in Period
	=	0	/	0	*	365 / 4
	=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cotinga Pharmaceuticals's Inventory Turnover for the quarter that ended in Jan. 2020 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Jan. 2020 )	/	Average Total Inventories (Q: Jan. 2020 )
	=	0	/	0
	=	N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cotinga Pharmaceuticals's Inventory to Revenue for the quarter that ended in Jan. 2020 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Jan. 2020 )	/	Revenue (Q: Jan. 2020 )
	=	0	/	0
	=

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Cotinga Pharmaceuticals Total Inventories Related Terms

Thank you for viewing the detailed overview of Cotinga Pharmaceuticals's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Cotinga Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cotinga Pharmaceuticals Inc (OTCPK:COTQF) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

82 Richmond Street East, The Canadian Venture Building, Toronto, ON, CAN, M5C1P1

Website

http://www.cotingapharma.com

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

Cotinga Pharmaceuticals Headlines

From GuruFocus

Cotinga Pharmacueticals Announces Closing of Unit Offering

By GlobeNewswire GlobeNewswire • 05-22-2019

Cotinga Pharmaceuticals Reports Fiscal 2018 Third Quarter Financial and Operating Results

By GlobeNewswire GlobeNewswire • 04-03-2018